Circulating Tumor Cells, Prostate
Item Catalog Number: LC502088
This test is for metastatic prostate cancer prognosis and monitoring.
The Circulating Tumor Cell assay provides a measurement of cancer cells that have separated from a solid tumor site and are circulating in the bloodstream. Detecting the presence of circulating tumor cells in the blood shows clinical usefulness in the assessment of disease status and prognosis in patients with metastatic prostate cancer.
Fasting is not required prior to the blood draw.
This blood test cannot be ordered as part of a blood draw kit. Blood draws must be performed at a LabCorp Patient Service Center (or at Life Extension’s blood lab for those residing near Fort Lauderdale, Florida) Monday through Thursday only.
Results for this test take 4-6 weeks.